［1］   American Cancer Society. Cancer Facts and Figures, 2009［M］. Atlanta: American Society, 2009 ［2］   Zhang W, Xiang Y B, Liu Z W, et al. Trends analysis of common urologic neoplasm incidence of elderly people in Shanghai, 1973-1999 ［J］. Ai Zheng (Cahcer), 2004, 23(5): 555-558 ［3］   Philipp-Staheli J,Payne SR,Kemp CJ. p27 (Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer ［J］. Exp Cell Res, 2001, 264(1): 148-168 ［4］   Black R A, Rauch C T, Kozlosky C J, et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells ［J］. Nature ,1997, 385(6618): 729-733 ［5］   Garton KJ, Gough PJ, Blobel CP, et al. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1) ［J］. J Biol Chem, 2001, 276(41): 37993-38001 ［6］   Cerretti DP, Poindexter K, Castner BJ, et al. Characterization of the cDNA and gene for mouse tumor necrosis factor alpha converting enzyme (TACE/ANAM17) and its location to mouse chromosome 12 and human chromosome 2p25 ［J］. Cytokine, 1999, 11(8): 541-551 ［7］   Murphy G. The ADAMs: signalling scissors in the tumour microenvironment ［J］. Nat Rev Cancer ,2008, 8(12): 929-941 ［8］   Fenton JI, Hursting SD, Perkins SN, et al. Interleukin-6 production induced by leptin treatment promotes cell proliferation in an Apc (Min/+) colon epithelial cell line ［J］. Carcinogenesis, 2006, 27(7): 1507-1515 ［9］   Katakowski M, Jiang F, Zheng X, et al. Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17 ［J］. Cancer Sci, 2009, 100 (9): 1597-1604 ［10］   Zheng X,Jiang F,Katakowski M,et al.ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation ［J］.Cancer Biol Ther,2009, 8 (11):1045-1054 ［11］   McCulloch DR, Harvey M,Herington AC. The expression of the ADAMs proteases in prostate cancer cell lines and their regulation by dihydrotestosterone［J］. Mol Cell Endocrinol, 2000, 167(1-2): 11-21 ［12］   Karan D, Lin FC, Bryan M, et al. Expression of ADAMs(a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas ［J］. Int J Oncol, 2003, 23 (5): 1365-1371 ［13］   Lee DC, Sunnarborg SW, Hinkle CL, et al. TACE/ADAM17 processing of EGFR ligands indicates a role as a physiological convertase ［J］. Ann NY Acad Sci, 2003, 995: 22-38 ［14］   Gordon JA, Sodek J, Hunter GK, et al. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells ［J］. J Cell Biochem, 2009, 107 (6): 1118-1128 ［15］   Yue H, Song FL, Zhang N, et al . Expression of p27(kip1), Rb protein and proliferating cell nuclear antigen and its relationship with clinicopathology in human pancreatic cancer［J］. Hepatobiliary Pancreat Dis Int, 2003, 2(1): 142-146 ［16］   张岩,刘贤锡,张冰,等.鸟氨酸脱羧酶基因反义RNA对前列腺癌细胞生长的抑制作用［J］. 中国生物化学与分子生物学报(Zhang Yan, Liu Xian-Xi, Zhang Bing, et al. Inhibition of prostate cancer cells with antisense RNA of ornithine decarboxylase gene［J］.Chin J Biochem Mol Biol), 2005, 21 (1) : 128-133 ［17］   Osaki M, Oshimura M, Ito H. PI3K-Akt pathway: its functions and altertions in human cancer［J］. Apoptosis, 2004, 9(6): 667-676 ［18］   Kanda S, Kanetake H, Miyata Y. Loss of PTEN function may account for reduced proliferation pathway sensitivity to LY294002 in human prostate and bladder cancer cells ［J］. J Cancer Res Clin Oncol, 2009, 135 (2): 303-311 ［19］   Wang B, Han L, Chen R, et al. Downregulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro ［J］. Cancer Biol Ther, 2009, 8 (11): 1018-1023 ［20］   Finzi L, Shao MX, Paye F, et al. Lipopolysaccharide initiates a positive feedback of epidermal growth factor receptor signaling by prostaglandin E2 in human biliary carcinoma cells ［J］. J Immunol, 2009, 182(4): 2269-2276 ［21］   Rishi AK, Parikh R, Wali A, et al. EGF receptor-related protein (ERRP) inhibits invasion of colon cancer cells and tubule formation by endothelial cells in vitro ［J］. Anticancer Res, 2006, 26(2A): 1029-1037 ［22］   Abouantoun TJ, Macdonald TJ. Imatinib blocks migration and invasion of medulloblastoma cells by concurrently inhibiting activation of platelet-derived growth factor receptor and transactivation of epidermal growth factor receptor ［J］. Mol Cancer Ther, 2009, 8: 1137-1147